Grace Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ADAR1 Capital Management, LLC(9.99%),ADAR1 Capital Management GP, LLC(9.99%), etc.
Grace Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANK OF AMERICA CORP /DE/(4.9%)
Acasti Pharma | 3/A: Initial statement of beneficial ownership of securities (Amendment)-10% Owner ADAR1 Capital Management, LLC
Acasti Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-ADAR1 Capital Management, LLC(10.20%),ADAR1 Capital Management GP, LLC(10.20%), etc.
Acasti Pharma | 3: Initial statement of beneficial ownership of securities-10% Owner ADAR1 Capital Management, LLC
Acasti Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer D'Andrea Carrie
Acasti Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Kumar Amresh
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer D'Andrea Carrie
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Amresh
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Macdonald R. Loch
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer DelAversano Robert J
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kohli Prashant
Acasti Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(6.0%),Orin H(6.0%)
Acasti Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BANK OF AMERICA CORPORATION(5.3%)
Acasti Pharma | 3: Initial statement of beneficial ownership of securities-Officer DelAversano Robert J
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kavuru Vimal
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kottayil George
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director NEUGEBOREN EDWARD
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director DAVIS A BRIAN
Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Kohli Prashant
No Data